Nonalcoholic Fatty Liver Disease Predicts Acute Kidney Injury Readmission in Heart Failure Hospitalizations: A Nationwide Analysis.


Journal

Current problems in cardiology
ISSN: 1535-6280
Titre abrégé: Curr Probl Cardiol
Pays: Netherlands
ID NLM: 7701802

Informations de publication

Date de publication:
Oct 2023
Historique:
received: 10 05 2023
accepted: 13 05 2023
pubmed: 22 5 2023
medline: 22 5 2023
entrez: 21 5 2023
Statut: ppublish

Résumé

Nonalcoholic fatty liver disease (NAFLD) has been associated with the progression of chronic kidney disease. However, limited data is available on its impact on acute kidney injury (AKI) in heart failure(HF) patients. All primary adult HF admissions from the national readmission database of 2016-2019 were identified. Admissions from July to December of each year were excluded to allow 6 months of follow-up. Patients were stratified according to the presence of NAFLD. Complex multivariate cox regression was used to adjust for confounders and calculate the adjusted hazard ratio. A total of 420,893 weighted patients admitted with HF were included in our cohort, of whom 780 had a secondary diagnosis of NAFLD. Patients with NAFLD were younger, more likely to be female, and had higher rates of obesity and diabetes mellitus. Both groups had similar rates of chronic kidney disease irrespective of the stage. NAFLD was associated with an increased risk of 6-month readmission with AKI (26.8% vs 16.6%, adjusted hazard ratio:1.44, 95% CI [1.14-1.82], P = 0.003). The mean time to AKI readmission was 150 ± 44 days. NAFLD was associated with a shorter mean time to readmission (145 ± 45 vs 155 ± 42 days, β =  -10 days, P = 0.044). Our study from a national database suggests that NAFLD is an independent predictor of 6-months readmission with AKI in patients admitted with HF. Further research is warranted to validate these findings.

Identifiants

pubmed: 37211306
pii: S0146-2806(23)00233-5
doi: 10.1016/j.cpcardiol.2023.101816
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

101816

Informations de copyright

Copyright © 2023 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Ahmed Hashim (A)

Ain Shams University, Faculty of Medicine, Cairo, Egypt.

Ahmed Maraey (A)

Department of Internal Medicine, Carle Foundation Hospital, Urbana, IL. Electronic address: maraeyahmed@gmail.com.

Ahmed Elzanaty (A)

Department of Cardiovascular Medicine, University of Toledo, Toledo, OH.

Magdi Zordok (M)

Department of Internal Medicine, Catholic Medical Center, Manchester, NH.

Hadeer Elsharnoby (H)

Department of Internal Medicine, Carle Foundation Hospital, Urbana, IL.

Mahmoud Khalil (M)

Department of Internal Medicine, Lincoln Medical Center, Bronx, NY.

Omar Al Wahadneh (O)

Department of Internal Medicine, Carle Foundation Hospital, Urbana, IL.

Helmy Siragy (H)

Department of Internal Medicine, University of Virginia Health System, Charlottesville, VA.

Classifications MeSH